Acute Kidney Injury In Hypertensive Crisis And Acute Congestive Heart Failure
Bilal Hussain,Suganya Manoharan,Dishang Bhavsar,Pradeep Kumar Devarakonda,Saikrishna Patibandla,Daniel Abascal-Gonzalez,Sohrab Singh,Keerthi Reddy Ramireddy,Cesar Ayala-Rodriguez,Sarath Reddy
DOI: https://doi.org/10.1016/j.cardfail.2023.10.338
IF: 6.592
2024-01-01
Journal of Cardiac Failure
Abstract:Background Literature suggests that hypertensive crisis (HTNC) can cause end-organ damage resulting in acute kidney injury (AKI). HTNC also leads to increased ventricular-vascular uncoupling and elevated left ventricular filling pressure which can eventually result in pulmonary edema and acute congestive heart failure (ACHF). Our goal is to study AKI and other outcomes of HTNC in patients with and without ACHF. Methods National Inpatient Sample 2016-2019 was queried to identify a cohort of patients admitted for HTNC, ACHF and AKI using respective ICD-10 codes. Primary outcome was the risk of developing AKI in HTNC patients with and without ACHF and its prognostic impact in terms of mortality. Multivariate logistic regression model was used for adjusted outcome analysis. Results Within the study population of 142 million patients, 2167985 patients (1.5%) were hospitalized for HTNC out of which 413465 patients had ACHF (19%). Within this HTNC population with ACHF, 168115 patients developed AKI (40.6%). On subgroup analysis of ACHF, AKI developed in 66355 patients with ACHF with preserved ejection fraction (AHEpEF) (39.4%) and in 49345 patients with ACHF with reduced EF (AHFrEF) (29.4%). On patient demographic analysis, mean age of patients with HTNC and ACHF developing AKI was 65 years, 52.5% were males, 47.5% were females, 43% were white, 39% were African-American and 11% were Hispanic. On adjusted outcomes analysis, ACHF was associated with 108% higher odds of developing AKI in HTNC patients (OR 2.08, CI 1.05-2.2, p<0.001), while AHFpEF was associated with slightly increased odds of developing AKI as compared to AHFrEF (OR 1.96, CI 1.92-2, p<0.001 vs OR 1.7, CI 1.65-1.64, p<0.001). In terms of mortality, AKI was associated with significantly higher odds of mortality in ACHF patients (OR 2.97, CI 2.65-1.3, p<0.001), these odds were higher in AHFrEF as compared to AHFpEF (OR 3.51, CI 2.8-4.4, p<0.001 vs OR 2.85, CI 2.4-3.3, p<0.001). We also studied the rates of other complications of HTNC which are summarized in Table 1. However, on multivariate analysis, ACHF was associated with significantly increased risk of only AMI in HTNC patients (OR 2.25, CI 2.2-2.3, p<0.001) Conclusion In HTNC, ACHF is associated with higher risk of developing AKI which is also associated with increased mortality in this patient population, AHFrEF more than AHFpEF. ACHF is also associated with higher risk of AMI in HTNC patients which can because of cardiomyocyte death and scar formation in AMI, which can stimulate chronic neurohumoral activation including renin-angiotensin-aldosterone and sympathetic nervous system and ventricular remodeling and cause ACHF. This supports that multi-disciplinary ‘cardio-nephrology’ clinical care is essential to optimize cardiac outcomes in HTNC.
cardiac & cardiovascular systems